Streetbeat News

Price Targets

UDR

Mizuho analyst Haendel St. Juste has maintained a Neutral rating on UDR, Inc. (NYSE:UDR) but lowered the price target from $38 to $34.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:13 pm

ABBV

Goldman Sachs analyst Chris Shibutani has upgraded AbbVie (NYSE:ABBV) from Neutral to Buy and set a price target of $173.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:13 pm

MAA

Mizuho analyst Vikram Malhotra has maintained a Neutral rating on Mid-America Apartment (NYSE:MAA) but has lowered the price target from $133 to $124.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:11 pm

CPT

Mizuho analyst Haendel St. Juste has maintained a Buy rating on Camden Property Trust (NYSE:CPT) but has reduced the price target from $101 to $95.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:09 pm

KHC

Evercore ISI Group analyst David Palmer has upgraded Kraft Heinz (NASDAQ:KHC) from In-Line to Outperform and increased the price target from $40 to $42.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:07 pm

AVB

Mizuho analyst Haendel St. Juste has maintained a Neutral rating on AvalonBay Communities (NYSE:AVB) but reduced the price target from $186 to $176.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:07 pm

POR

Barclays analyst Nicholas Campanella upgraded Portland Gen Electric (NYSE:POR) from Equal-Weight to Overweight and set a price target of $47.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:06 pm

IQV

IQVIA Hldgs (NYSE:IQV) received 12 analyst ratings in the last quarter, with an average 12-month price target of $232.33, a decrease from the previous target of $243.70. The ratings include 5 bullish, 5 somewhat bullish, and 2 indifferent, with no bearish sentiments. The high price target is $260.00 and the low is $202.00.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 1:01 pm

WAT

Over the past 3 months, 7 Wall Street analysts have provided ratings for Waters Corporation (NYSE:WAT) with an average price target of $270.71, which is a 4.17% decrease from the previous target of $282.50 and implies a downside from the current price of $292.14. The consensus among these analysts is largely indifferent, with 6 neutral ratings and 1 somewhat bearish rating. No bullish ratings were provided.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 1:00 pm

ILMN

Citigroup analyst Patrick Donnelly upgraded Illumina (NASDAQ:ILMN) from Sell to Neutral and increased the price target from $85 to $120.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:00 pm